Abstract
The present study does not suggest that somatostatin-14 is handled by the kidney in a manner that is qualitatively different from other small peptides but it appears that the kidney plays only a relatively minor role in the in vivo clearance in comparison to the many other sites of degradation.
| Original language | English |
|---|---|
| Pages (from-to) | 151-152 |
| Number of pages | 2 |
| Journal | Hormone and Metabolic Research |
| Volume | 16 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1984 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Biochemistry
- Endocrinology
- Clinical Biochemistry
- Biochemistry, medical
Fingerprint
Dive into the research topics of 'Unimpaired clearance of somatostatin-14 in chronic renal failure'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS